We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
National Research Corp. (MM) | NASDAQ:NRCI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.10 | 0 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Hays Michael D. |
2. Issuer Name
and
Ticker or Trading Symbol
NATIONAL RESEARCH CORP [ NRCI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director __ X __ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) CEO |
C/O NATIONAL RESEARCH CORPORATION, 1245 "Q" STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
LINCOLN, NE 68508 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 2/28/2013 | G | V | 125000 | D | $0 | 3615215 (1) | D | ||
Common Stock | 2/28/2013 | G | V | 125000 | D | $0 | 125250 (2) | I | By Spouse | |
Common Stock | 25 | I (3) | By Spouse & Daughter Jt |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (right to buy) | $16.1 | (4) | 1/5/2014 | Common Stock | 18298 | 18298 | D | ||||||||
Employee Stock Option (right to buy) | $17.25 | (5) | 1/5/2016 | Common Stock | 11078 | 11078 | D | ||||||||
Employee Stock Option (right to buy) | $22.87 | (6) | 1/5/2017 | Common Stock | 8356 | 8356 | D | ||||||||
Employee Stock Option (right to buy) | $26.5 | (7) | 1/4/2018 | Common Stock | 7211 | 7211 | D | ||||||||
Employee Stock Option (right to buy) | $28.51 | (8) | 1/5/2019 | Common Stock | 6703 | 6703 | D | ||||||||
Employee Stock Option (right to buy) | $21.65 | (9) | 1/5/2020 | Common Stock | 8827 | 8827 | D | ||||||||
Employee Stock Option (right to buy) | $32.31 | (10) | 1/5/2021 | Common Stock | 5915 | 5915 | D | ||||||||
Employee Stock Option (right to buy) | $38.35 | (11) | 1/5/2022 | Common Stock | 4983 | 4983 | D | ||||||||
Employee Stock Option (right to buy) | $52.42 | (12) | 1/7/2023 | Common Stock | 3646 | 3646 | D |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Hays Michael D.
C/O NATIONAL RESEARCH CORPORATION 1245 "Q" STREET LINCOLN, NE 68508 |
X | X | CEO |
|
Signatures
|
||
/s/ Russell E. Ryba, Attorney-In-Fact for Michael D. Hays | 3/18/2013 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year National Research Corp. (MM) Chart |
1 Month National Research Corp. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions